Results 221 to 230 of about 15,808,373 (394)

A possible turning point for research governance in the life sciences. [PDF]

mSphere
Gillum DR.
europepmc   +1 more source

Acoustic tweezers for the life sciences

Nature Methods, 2018
Adem Ozcelik, Joseph Rufo, Feng Guo, Yuyang Gu, Peng Li, James P. Lata, T. Huang   +6 more
semanticscholar   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Molecular life sciences in the era of the Fourth Industrial Revolution: sequencing, multi-omics and artificial intelligence. [PDF]

Emerg Top Life Sci
Keenan L, Lorna Younger R, Race PR, Bawn M.   +3 more
europepmc   +1 more source

Animals in a bacterial world, a new imperative for the life sciences

Proceedings of the National Academy of Sciences of the United States of America, 2013
M. McFall-Ngai, M. Hadfield, T. Bosch, H. Carey, Tomislav Domazet-Lošo, A. Douglas, N. Dubilier, G. Eberl, T. Fukami, S. Gilbert, U. Hentschel, N. King, S. Kjelleberg, A. Knoll, N. Kremer, S. Mazmanian, J. Metcalf, K. Nealson, N. Pierce, J. Rawls, A. Reid, E. Ruby, M. Rumpho, J. Sanders, D. Tautz, J. Wernegreen   +25 more
semanticscholar   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

BioBricks.ai: a versioned data registry for life sciences data assets. [PDF]

Front Artif Intell
Gao Y, Mughal Z, Jaramillo-Villegas JA, Corradi M, Borrel A, Lieberman B, Sharif S, Shaffer J, Fecho K, Chatrath A, Maertens A, Teunis MAT, Kleinstreuer N, Hartung T, Luechtefeld T.   +14 more
europepmc   +1 more source

A practical guide to photoacoustic tomography in the life sciences

Nature Methods, 2016
Lihong V. Wang, Junjie Yao
semanticscholar   +1 more source

Health and life sciences [PDF]

, 2000
The Hungarian Technology Foresight Programme, Ministry of Education of the Republic of Hungary
core  

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source